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Increased synthesis of extraceHular matrix in mesangial proliferative
nephritis. Extracellular matrix expansion is frequently noted in mesan-
gioproliferative renal diseases. This study investigates the role of
immunologic factors in glomerular matrix accumulation. The gene
expression of type I and IV collagen, laminin and s-laminin was
examined in the rat model of mesangial proliferative glomerulonephritis
induced with anti-Thy 1.1 antibody. Northern analysis was performed
on glomerular RNA isolated one, three and five days after disease
induction and at day 3 following prior complement depletion. Tissue
was immunostained for the protein products of these genes as well as
for heparan sulfate proteoglycan, entactin and PCNA (a marker of cell
proliferation) at days 1,3, 5, 14,21 and 42. A seven- to ten-fold increase
of collagen IV and laminin mRNA as well as de novo expression of
collagen I mRNA occurred at days 3 and 5 corresponding to the time of
maximal proliferation. S-laminin mRNA levels only increased three-
fold. With the exception of s-laminin, mesangial staining for all exam-
ined matrix proteins increased to a maximum at day 5 and decreased
thereafter. Focal alterations of the glomerular architecture and matrix
persisted at day 42. Complement depletion prevented the histological
abnormalities as well as the increased expression of matrix proteins at
day 3. These findings indicate that immunologic injury in the mesan-
gium may result in overproduction of extracellular matrix components
and may ultimately contribute to the development of glomerulosciero-
sis.
The progressive accumulation of extracellular matrix in the
mesangium resulting in glomerular sclerosis occurs in a number
of progressive renal diseases of both immune and non-immune
etiology, including IgA nephropathy, focal glomerulosclerosis
and diabetic nephropathy [1]. Most studies of the composition
of the sclerotic lesion suggest that it represents an accumulation
of normal constituents of the extracellular matrix including type
IV and V collagen and laminin [2—4] as well as abnormal,
interstitial (type I and III) collagens [5, 61. The mechanisms
responsible for the development of sclerosis remain controver-
sial with hemodynamic factors, lipid accumulation and glomer-
ular hypertrophy all hypothesized to play a role [reviewed in 1].
In addition, recent studies have strongly implicated a role for
transforming growth factor-a (TGF-f3), which may be released
by monocyte-macrophages, platelets or the mesangial cells
themselves [reviewed in 7] in several models of glomerular
disease [8—10].
The normal mesangial matrix consists mainly of type IV and
V collagen, laminin, fibronectin and several proteoglycan spe-
cies [2—4, 8, 9], while entactin is only present in trace quantities
[11] and no s-laminin or collagen I are detectable [5, 12]. In the
present study, we have examined the role of immunologically-
mediated mesangial cell injury to induce glomerular matrix
accumulation and ultimately sclerosis. Utilizing the model of
mesangial proliferative glomerulonephritis induced with anti-
Thy 1.1 antibody [13], we examined the effects of acute
antibody mediated mesangial injury on glomerular gene expres-
sion as well as protein content and distribution of types I and IV
collagen, laminin and s-laminin. We also examined the glomer-
ular content and distribution of the normal glomerular basement
constituents heparan sulfate proteoglycan and entactin/ni-
dogen. Data on the remaining matrix components fibronectin
and low molecular weight proteoglycans have recently been
reported by other authors [8, 9]. Our results document a
substantial increase in the mesangial content of normal (type
IV) [14] and abnormal (type I) [5, 6] collagens, entactin,
heparan sulfate proteoglycan and of laminin (but not of s-lami-
nm) during the proliferative phase of anti-Thy 1.1 induced
mesangial proliferative glomerulonephritis. The increase in
matrix proteins was associated with an upregulation of type I
and IV collagen and laminin gene expression in glomeruli.
Complement depletion abolished these changes. Our findings
indicate that in situ immune complex formation with consecu-
tive complement activation in the mesangiurn may initiate and
sustain an overproduction of extracellular matrix components
that may contribute to the later development of glomeruloscler-
osis.
Materials
Disease model and experimental protocol
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In this study, the rat anti-Thy 1.1 model [13] of mesangial
proliferative glomerulonephritis was examined. In the anti-Thy
1.1 model, acute mesangiolysis is induced by injection of
anti-thymocyte antibody which also recognizes mesangial cells
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by virtue of their expression of the Thy 1.1 antigen on their cell
surface. Goat anti-rat thymocyte plasma was raised as previ-
ously described [15]. Following injection of this plasma (0.4
nil/100 g body wt) into a tail vein, 33 male Wistar rats (Simon-
son, Gilroy, California, USA) were studied in groups of six at
days 1, 3, 5, 14, 21 and 42 (N = 3). Six additional rats were
complement depleted with cobra venom factor (CVF), and
examined three days after induction of glomerulonephritis with
anti-Thy 1.1 antibody. Six normal aged-matched, unmanipu-
lated Wistar rats were studied as controls.
In each group, kidney biopsies were obtained at the specified
times mentioned above. Following this the rats were sacrificed
and glomeruli from all kidneys in each group were isolated and
pooled. RNA was extracted from the glomeruli and Northern
analysis was performed using cDNA probes specific for laminin
B2 chain, s-laminin, and type I and IV collagens. The glomer-
ular localization of the s-laminin, laminin, type I and IV
collagen gene products as well as of heparan sulfate proteogly-
can and entactin was determined immunohistologically. In
addition, the overall degree of glomerular matrix accumulation,
the total cell number and the number of proliferating glomerular
cells [as defined by staining for the proliferating cell nuclear
antigen (PCNA)] per glomerular cross section was determined.
Complement depletion
Rats were depleted of complement with CVF (Naja naja
kaounthia, Diamedix Corporation, Miami, Florida, USA) [16].
Rats were injected with CVF 30 U/rat/day i.p. in three divided
doses beginning 24 hours prior to injection of anti-thymocyte
plasma, followed by an additional daily dose of 10 U/rat i.p.
until sacrifice. Serum was collected prior to the injection of
CVF (baseline value), at the time of injection of anti-Thy 1.1
plasma, and at sacrifice. Serum C3 levels, measured by radial
immunodiffusion [16], of <10% baseline value were maintained
throughout the study period.
Renal morphology
Tissue for light microscopy and immunohistochemistry was
fixed in methacarn solution, transferred to methanol, rinsed in
xylene and embedded in paraffin. Three micron histologic
sections were stained with the periodic acid Schiff (PAS)
reagent. Glomerular cellularity was evaluated by counting the
total number of nuclei in 20 representative glomerular cross
sections containing >20 discrete capillary segments/cross sec-
tion. For the determination of the degree of glomerular sclerosis
three micron sections were stained with silver methenamine.
Electron microscopy
Tissue for electron microscopy was fixed, processed and
examined as described previously [17].
Immunohistochemical staining for type I and IV collagen,
laminin, s-laminin, heparan sulfate proteoglycan, entactin,
and PCNA
Tissue was processed by an indirect immunoperoxidase
technique as previously described [15]. Primary antibodies
included an IgG fraction of polyclonal rabbit anti-rat collagen I
(Chemicon, Temecula, California, USA; 10 /Lg/ml), an IgG
fraction of polyclonal rabbit anti-mouse collagen IV (Collabo-
rative Research Inc., Badford, Massachusetts, USA; 3 jig/mI),
an IgG fraction of polyclonal rabbit anti-rat laminin (Chemicon;
2 jig/ml), the monoclonal mouse anti-rat s-laminin antibodies
"D5" and "D7" (gifts of J. Sanes [121; 1:250), an IgG fraction
of a polyclonal rabbit anti-mouse against the core protein of
heparan sulfate proteoglycan (used at 3 jig/ml; gift of J.R.
Couchman) [18], an IgG fraction of polyclonal rabbit anti-
mouse entactin (used at 5 jig/mI; gift of A.E. Chung) [19], and
19A2, a murine 1gM monoclonal antibody against human PCNA
(American Biotech Inc., Plantation, Florida, USA) (1:1000
dilution). PCNA is an auxiliary protein to DNA polymerase-;
nuclear expression of this protein is absent in the G0 and early
G1 phase of the cell cycle and increases in the late G1 phase with
a further increase in the S phase, followed by a decrease in
G2/M [201. The anti-PCNA antibody 19A2 has been shown
previously to detect proliferating cells in methacarn-fixed rat
tissues [15]. For all biopsies, negative controls consisted of
substitution of the primary antibody with an irrelevant murine
monoclonal antibody or normal rabbit IgG.
For the evaluation of the types IV and I collagen, laminin,
heparan sulfate proteoglycan and entactin staining, each gb-
merulus was graded semiquantitatively. Each score reflects
mainly changes in the extent rather than intensity of mesangial
matrix staining):
0 - Diffuse, very weak or absent mesangial matrix staining.
No localized increases of staining.
1+ - Diffuse, weak mesangial matrix staining with 1 to 25% of
the glomerular tuft showing focally increased staining.
2+ - 25 to 50% of the glomerular tuft demonstrating a focal,
strong staining.
3 + - 50 to 75% of the glomerular tuft stained strongly in a focal
manner.
4+ - >75% of the glomerular tuft stained strongly.
For each biopsy 30 to 40 glomerular cross sections containing
>20 discrete capillary segments were evaluated by a blinded
observer, and mean values per biopsy were calculated. Glomer-
uli with large microaneurysms replacing more than half of the
glomerular tuft, primarily seen at day five after disease induc-
tion, were excluded in this evaluation.
Immunofluorescence staining for s-laminin
Immunofluorescence detection of glomerular s-laminin was
carried out on 4 jim sections of frozen, previously unfixed
kidney tissue using an indirect immunofluorescence procedure,
as described elsewhere [21. For the primary antibody the "D5"
monoclonal mouse anti rat s-laminin antibody (vide supra) was
used followed by a biotinylated sheep anti-mouse IgG antibody
and FITC-coupled avidin (both from Amersham, Arlington
Heights, Illinois, USA). The relative amount of s-laminin
present in the glomeruli was assessed semiquantitatively by
determining the end-point dilution of the first antibody at which
the antigen was still clearly detected by immunofluorescence.
Isolation of glomeruli and preparation of glomerular RNA
Glomeruli were isolated by differential sieving [15]. In order
to preserve the integrity and stability of the glomerular RNA all
isolation steps were performed at 4°C using diethyl pyrocarbon-
ate (DEPC) treated PBS, baked or autoclaved sieves and
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glassware and using as little time as possible for the prepara-
tion. Less than 25 minutes elapsed from nephrectomy to
dissolution of the isolated glomeruli in solution D [171. To affirm
that differential sieving of diseased glomeruli does not select a
subpopulation of glomeruli which differs in composition from
glomeruli in situ, a separate experiment was performed, in
which glomeruli were isolated from a rat immediately following
renal biopsy five days after injection of anti-thymocyte plasma.
These isolated glomeruli were then fixed in methacarn solution
and processed for light microscopy and immunohistochemistry
as described above.
Total RNA was extracted from isolated glomeruli utilizing the
method of Chomczynski and Sacchi [211 as previously de-
scribed [17].
RNA gel electrophoresis and blotting
Total glomerular RNA was denatured with formamide and
formaldehyde, and electrophoresed through a 1% agarose gel
(15 tg RNA/lane), containing 2.2 M formaldehyde/0.2 M MOPS
pH 7.0, transferred to a nylon filter (Zeta-Probe, Bio-Rad,
Richmond, California, USA) overnight by capillary blotting in
lox SSC-buffer (1.5 M NaCI, 0.15 M sodium citrate, pH 7), and
baked at 80°C for two hours [171. Examination of the membrane
under short wave UV light in the presence of ethidium bromide
demonstrated good resolution and integrity of the 28S and 18S
ribosomal RNA bands.
DNA probes and hybridization conditions
The cDNA probes used for Northern analysis were as fol-
lows:
1) Type I collagen. An ECO RI fragment of human a! (I)
collagen from cDNA clone HF 677 of 1.4 kb was used to detect
the 5.7 and 4.7 kb transcripts of collagen I [22]. The probe was
a gift of M. Chu and L. Sandell.
2) Type IV collagen. A 1.8 kb ECO RI/Hind III fragment of
mouse al (IV) collagen cDNA from plasmid pPE123 was used
for the detection of the 6.2 and 6.8 type IV collagen transcript
[23]. The probe was a gift of M. Kurkinen.
3) Laminin B2 chain. A 1.7 kb ECO RI/Xba I fragment of
mouse laminin B2 cDNA isolated from plasrnid p1298 was used
to detect the 8 kb laminin B2 transcript [24]. The probe was a
gift of Y. Yamada.
4) s-Laminin. A 2.5 kb ECO RI fragment from cDNA clone
RK65-6 from a rat kidney library was used to detect the 5.7 kb
s-laminin mRNA transcript [12]. The probe was a gift of J.
Sanes.
All probes were labelled with [c-32P]-deoxycytidine 5-tn-
phosphate (3000 Ci/mmol, New England Nuclear, Boston,
Massachusetts, USA) by random primer extension. In prelim-
inary experiments all of these probes have been shown to cross
hybridize with the respective rat RNA's. Positive controls
included total RNA isolated from BALB/c 3T3 fibroblasts
(collagen I), mouse F9 cells (collagen IV) and cultured rat aortic
smooth muscle cells (laminin B2 chain, s-laminin).
Membranes were prehybridized in a solution containing 50%
(vol/vol) formamide, 5x SSPE (lx SSPE = 0.18 M NaCl, 0.01
M NaH2PO4, 0.001 M EDTA), 5 x Denhardts, 0.1% SDS and 100
sg of salmon sperm DNA per ml. Hybridization was performed
with the same solution, to which 1 to 2 x 106 cpm/ml of
32P-labelled cDNA was added, for 24 hours at 42°C, Blots were
Table 1. Cellularity and number of proliferating cells in glomerular
cross sections of normal rats, rats with anti-Thy 1.1
glomerulonephnitis (GN) or in complement-depleted (CVF) rats with
anti-Thy 1.1 glomerulonephritis
Group N
Total cells
per glomerular
cross section
PCNA-positive cells
per glomerular
cross section
Normal controls 6 76.5 i 1.8 0.9 0.5
GN day 1 6 67.5 0.4 1.2 0.1
GN day 3 6 95.7 2.4a 21.8 2.7a
GN day 5 6 106.8 2.7a 20.1 0.8a
GN day 14 6 85.7 4.Oa 0.9 0.6
GN day 21 6 83.4 4,3a 0.6 0.4
GN day 42
CVF + GN day 3
3
6
81.4 3.6
80.9 2.Ob
0.7 0.1
1.4
Portions of this table have been reported in a separate study inves-
tigating the expression of a-smooth muscle actin in anti-Thy 1.1
glomerulonephritis [171 (used with permission).
a P < 0.01 relative to normalb P < 0.01 relative to ATS day 3
then washed three times in 2x SSPE, 0.1% SDS for five
minutes each at room temperature and then in 0.1 X to lx
SSPE, 0.1% SDS at 50 to 60°C depending on stringency
conditions required. After drying, membranes were Saran
wrapped and exposed to non-preflashed Kodak X-O MAT film
(Eastman Kodak, Rochester, New York, USA) with enhancing
screens at —70°C. The resulting autoradiograms were read by
linear densitometry (Beckman Model R-1 12) at 600 nm. Some
membranes were rehybridized with additional probes (up to a
maximum of 4x); these membranes were stripped in 0.01 x
SSPE, 0.5% SDS for 20 minutes at 95°C prior to rehybridiza-
tion.
Quantitarion of ,nRNA
To quantify the amount of mRNA present on the membranes,
autoradiograms were scanned with a laser densitometer (Beck-
man Model R-ll2) at 600 nm. Densitometry was then normal-
ized for equivalent amounts of 28S ribosomal RNA per lane as
determined by hybridization to a specific bovine 280 bp cDNA
probe for 28S ribosomal RNA (provided by Dr. Luisa Iruela-
Arispe and Dr. Helene Sage). Hybridization with the 28S cDNA
probe was performed under conditions and probe concentra-
tions that gave a linear relationship between densitometry
signal and amount of RNA loaded (range tested: 2.5 to 15
gIlane total RNA, r2 = 0.99). Values are expressed as optical
density units relative to the specific mRNA level observed in
glomerular RNA from normal rats.
Statistical analysis
All values are expressed as mean SD. Statistical signifi-
cance (defined as P < 0.05) was evaluated using the Student's
t-test or one way analysis of variance with modified t-tests
performed using the Bonferroni correction.
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Fig. 1. Glomerular silver methenamine staining of tissue obtained from a normal rat (a) and rats with anti-Thy 1.1 g!omeru!onephritis at day 5
(b), day 14 (c) andday 42 (d). At day 5 there is an increase in mesangial cells in most glomeruli while an increase of silver staining matrix is only
noted occasionally (b). The silver staining matrix is loosely organized and has a fibrillar appearance (b). By day 14 the mesangial architecture has
returned to normal in most glomeruli, although an increase in silver staining matrix compared to normal is readily apparent (c). By day 42 there
is persistent segmental increase in silver staining mesangial matrix in about a third of the glomeruli (d). x400.
Results
Histological changes and effect of complement depletion
during anti-Thy 1.1 glomerulonephritis
Following injection of anti-thymocyte plasma, rats developed
mesangiolysis with subsequent mesangial hypercellularity fol-
lowed by resolution of the disease (Table 1) as previously
reported [13, 16, 25]. Total cellularity decreased by 12% on day
1 after disease induction, consistent with the loss of mesangial
cells. At days 3, 5, 14 and 21 after disease induction total
cellularity was significantly increased (Table 1). This was par-
alleled by a significant increase of the number of PCNA-positive
cells at days 3 and 5 (Table 1). At later stages total cellularity as
well as PCNA staining decreased to the normal range (Table I).
Silver methenamine staining of tissue obtained at day 5 (Fig.
lB) showed no significant increase above normal (Fig. 1A),
although in many damaged glomeruli the pattern of silver
staining was altered. Areas of mesangiolytic injury showed at
times complete or near complete loss of silver staining matrix.
while in occasional glomeruli a fine granular pattern of staining
appeared in the mesangium (Fig. lB). In contrast, at day 14
about 50% of the glomeruli present showed an increase, often
segmental, in mesangial matrix detected by silver methenamine
staining (Fig. 1C). In 10 to 20% of the glomeruli, this was
associated with segmental obliteration of capillary lumina,
resulting in segmental sclerosis. Frequently the increase in
silver staining matrix occurred in segments of glomerular tufts
showing residual evidence of previous mesangiolytic injury and
microaneurysm formation. By day 21, similar patterns of silver
staining matrix accumulations were noted but were slightly
diminished in extent (both in percent of affected glomeruli and
in proportion of damaged segments in affected glomeruli),
suggesting a process of matrix remodelling in the damaged
glomeruli. Finally, on day 42 silver staining remained increased
in segmental areas of 30 to 40% of the glomeruli (Fig. ID). PAS
staining at this time-point demonstrated the persistence of
hypercellular lesions in about 30% of the glomeruli while other
glomeruli (about 15%) showed persistent segmental sclerotic
changes.
Electron microscopy of tissue obtained at day 14 demon-
strated the presence of fibrils with no periodicity and a mean
diameter of approximately 20 nm in an expanded mesangial
matrix (Fig. 2). Furthermore, a prominent rough endoplasmic
reticulum was observed in the mesangial cells, consistent with
increased biosynthetic activity (Fig. 2).
In agreement with prior studies [16, 25, 26], complement
depletion with CVF prevented both the mesangiolysis and
subsequent proliferation. Total cell counts as well as PCNA
positive cells per glomerular cross section obtained at day 3
were not significantly different from those obtained in normal
controls (Table 1).
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Fig. 2. Glomerular ultrastructure in anti-Thy 1.1 glomerulonephritis at
day 14 after disease induction. There is increased mesangial matrix with
collagenous fibrils ( jc") and synthetically active mesangial cells
("MC") with prominent rough endoplasmic reticulum ("er"). "CL" -
capillary lumen, "P" - podocyte, 'E" - endothelial cell. xll,300.
Glomerular immunohistochemical staining for type I and IV
collagen, laminin, heparan sulfate proteoglycan and entactin
a) Normal rats. At the antibody concentrations used, staining
for type I collagen in normal control animals was confined to
vessel walls (Fig. 3A). In very few glomeruli, the hilar portion
of the tuft showed positive staining for type I collagen, which
appears to be related to the continuation of the afferent and
efferent arteriole into the glomerulus. In the case of staining for
type IV collagen both the glomerular and tubular basement
membranes showed a weak, diffuse staining (Fig. 3B). Staining
of the mesangium for type IV collagen was either weak and
diffuse (= grade 0) or involved less than 50% of the mesangium
in a focal manner (= grades 1 and 2) (Fig. 3B). A similar staining
pattern was also observed for laminin, except that the mesan-
gial staining was less prominent as compared to type IV
collagen (Fig, 3C). Mesangial staining for heparan sulfate pro-
teoglycan in normal rats was variable ranging from weak,
diffuse staining to glomeruli with more than 50% of the mesan-
gium showing strong positivity (= grades 0 to 3) (Fig. 3D). In
contrast, intense staining of the glomerular basement mem-
brane was observed in most glomeruli (Fig. 3D). Weak glomer-
ular staining for entactin in normal rat kidney was confined to
the capillary wall and, except for an occasional weak staining of
the base of the glomerular tuft, no mesangial staining was
observed at the antibody concentration employed (= grade 0)
(Fig. 3E). Besides the glomerular basement membrane, positive
staining for entactin was present in vessel walls.
While for the anti-collagen IV, laminin and entactin antibody
glomerular basement membrane staining was either weak or
non-detectable (Fig. 3B, C, E, G, H, J) using the immunoper-
oxidase technique on paraffin-embedded sections, all of these
antibodies showed reactivity with the glomerular basement
membrane when used on cryostat sections with an immunoflu-
orescent method (data not shown).
b) Rats with anti-Thy 1.1 glomerulonephritis. No significant
differences from the normal staining scores were noted at day 1
after disease induction (Fig. 4). As shown by the staining scores
obtained at day 3 (Fig. 4), focal increases in types I and IV
collagen, laminin and entactin staining were detected in pre-
dominantly mesangial locations, while heparan sulfate proteo-
glycan staining showed no significant changes at this time point.
A marked, significant (P < 0.001 vs. normal) increase in
mesangial staining for type I and IV collagen, laminin, entactin
and now also including heparan sulfate proteoglycan, occurred
at day 5, when the whole tuft was affected in the majority of
glomeruli (Fig. 3F—J and 4). Areas of increased staining were
frequently associated with areas of mesangial hypercellularity
(Fig. 3F—J). At subsequent stages (days 14, 21 and 42) the extent
of focal staining decreased for all five proteins examined but,
with the exception of heparan sulfate proteoglycan staining, still
remained elevated in comparison to normal glomeruli (Fig. 4).
c) Complement-depleted rats with anti-Thy 1.1 glomerulone-
phritis. In the complement-depleted rats with anti-Thy 1.1
glomerulonephritis the staining for type I and IV collagen,
laminin, heparan sulfate proteoglycan, and entactin at day 3
after disease induction was not significantly different from the
staining observed in normal controls (Fig. 4).
Glomerular immunoperoxidase and i,'nmunofluorescent
staining for s-laminin
In normal glomeruli immunoperoxidase staining for s-laminin
using either the "D5" or "D7" antibody was confined to the
glomerular basement membrane and the basement membrane of
vessels, while no mesangial matrix staining was observed (Fig.
5A). No alteration of this staining pattern was detected at 1, 3 or
5 days (Fig. SB) after disease induction. However, since a
minor upregulation of s-laminin gene expression (vide infra)
was noted on day 3 and 5 and because s-iaminin is distributed
primarily in the glomerular basement membrane [12] and there-
fore difficult to assess by immunoperoxidase staining, immuno-
fluorescence microscopy was also utilized in the studies with
this antibody. This technique demonstrated a minor, non-
significant (P = 0.06 vs. normal) increase of the intensity of
immunofluorescent glomerular basement membrane staining in
several rats at either day 3 or 5 after disease induction (Table 2)
as opposed to complement-depleted rats at day 3, in which no
difference compared to the normal staining intensity occurred
(Table 2). As with the immunoperoxidase technique, no mesan-
gial staining for s-laminin could be detected by immunofluores-
cence in normal or diseased rats.
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Glomerular gene expression for type I and JV collagen,
laminin B2 chain and s-laminin
Northern analysis was performed with glomerular RNA from
normal rats and rats with anti-Thy 1.1 glomerulonephritis. To
ensure that the glomerular isolation using the sieving method
did not lead to a selective enrichment of a glomerular subpop-
ulation in diseased animals, an aliquot of isolated glomeruli
obtained at day 5 was PAS-stained as well as immunostained for
PCNA and laminin. When highly fragmented glomeruli were
neglected in the evaluation of the sections, PAS staining
showed glomeruli with all typical pathohistological changes
observed at this time after disease induction, that is, focal to
diffuse mesangial hypercellularity and large microaneurysms.
Staining for PCNA revealed 19.8 10.3 positive cells in intact
glomeruli (N = 35), which was in the range observed in the
renal biopsy taken prior to the glomerular isolation (20.8 8.1
positive cells/glomerular cross section; N = 30). Similar find-
ings were obtained in the case of immunohistochemical staining
for laminin. In isolated glomeruli a staining score of 3.5 0.7 (N
= 28) was noted as compared to a score of 3.2 0.9 (N = 39)
in the corresponding renal biopsy.
When the glomerular RNA isolates were used for hybridiza-
tion with the collagen I probe, no mRNA transcripts could be
detected in normal animals as well as at day 1 after disease
induction. Collagen I mRNA transcripts were, however, noted
at days 3 and 5 (Fig. 6) but were not quantified because the
non-detectable message levels in normal controls prevented
normalization of densitometry readings. In the case of collagen
IV, low mRNA levels were noted in normal rats (Fig. 6, Table
3). In rats with anti-Thy 1.1 glomerulonephritis an initial de-
pression of collagen IV mRNA occurred at day 1 (Table 3),
consistent with the transient reduction of glomerular cell num-
bers (Table 1). Thereafter, expression of collagen IV RNA
increased seven- to nine-fold at days 3 and 5 (Fig. 6). Linear
densitometry of the blots (Table 3) revealed maximum expres-
sion of collagen IV mRNA at day 5. A comparable pattern of
mRNA expression was also noted for laminin B2 and s-laminin
mRNA (Fig. 6, Table 3), although in the case of s-laminin the
increase was of a lesser magnitude than that observed with
laminin B2 chain or type IV collagen. The increased mRNA
expression of all four matrix components examined was re-
duced when the animals were complement depleted prior to
disease induction (Fig. 6, Table 3).
Discussion
In this study we have investigated the production of extra-
cellular matrix following selective mesangiolysis induced by
antibodies to the Thy 1.1 antigen on the mesangial cell surface
[13, 27]. The early mesangiolysis in the Thy 1.1 model has been
shown to be mediated by complement [this study and 16, 25, 261
and platelets [15], while neutrophils do not play a significant
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Fig. 4. Glomerular immunohistochemica! staining scores observed for
type I and IV collagen (A) as well as for the non-collagenous matrix and
basement membrane constituents laminin, entactin and heparan sul-
fate proteoglycan (B) in normal (NI) Wistar rats (filled bars), rats with
anti-Thy 1.1 glomerulonephritis (hatched bars) at days 1, 3, 5, 14, 21
and 42 after disease induction as well as in complement-depleted rats
(+ CVF) with anti-Thy 1.1 glomerulonephritis (open bars) at day 3. NS
- not significantly different from normals, p < 0.05, **p < 0.01,
<0.001 versus normal. nc. - no calculation of significance possible due
to N = 3 (N = 6 for all others).
Fig. 3. Immunohistochemical glomerular staining for type I collagen (a, f), type IV collagen (b, g), laminin (c, h), heparan sulfate proteoglycan
(d, i), and entactin (e, j) in normal Wistar rats (a-e) and in rats with anti-Thy 1.1 glomerulonephritis at day 5 (f-j) after disease induction. There
is increased mesangial staining for each of these matrix components in rats with glomerulonephritis. In addition, there is accentuation of basement
membranes for heparan sulfate proteoglycan. Immunoperoxidase with methyl green counterstain, x400).
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Fig. 5. Immunoperoxidase staining for s-laminin with the monoc/onal antibody D5 in normal rats (a) and rats with anti-Thy 1.1 glomerulonephritis
(b) at day 5 after disease induction. (x400)
Table 2. Relative glomerular content of s-laminin in normal rats, rats
with anti-Thy 1.1 glomerulonephritis (GN) or in complement-depleted
(CVF) rats with anti-Thy 1.1 glomerulonephritis
Group
Positive staining at dilution
1:15000 1:25000 1:40000 1:65000
Normal controls 5/5 1/5 0/5 0/5
GN day 1 5/5 1/5 0/5 0/5
GN day 3 5/5 4/5 1/5 0/5
GN day 5 4/4 3/4 1/4 0/4
CVF + GN day 3 5/5 1/5 0/5 0/5
Results represent the number of specimens in which the antigen was
still detected by immunofluorescence at the respective dilution.
No group was significantly different from normal controls.
role in the glomerular damage [13] and no autologous phase
develops [27j. Mesangiolysis is followed by a proliferation of
mainly mesangial cells, as shown by results of immunohisto-
chemical double labeling with antibodies directed against the
proliferating cell nuclear antigen (PCNA) and the Thy 1.1
antigen [unpublished results] and the data of previous studies,
which have excluded a significant proliferation of monocytes/
macrophages [25, 27] or CD45-positive leukocytes [15].
Our data show that the mesangial cell proliferation following
a single episode of selective mesangial injury was associated
with a complement-dependent accumulation of normal (type
IV) and abnormal (type I) glomerular collagens, laminin (but not
s-laminin), heparan sulfate proteoglycan and entactin. This
study thereby complements earlier data showing increased
mesangial deposition of small chrondroitin/dermatan-sulfate
proteoglycans as well as of fibronectin in anti-Thy 1.1 glomer-
ulonephritis [8, 9]. In parallel to the upregulation of matrix
protein expression, an increase of type I and IV collagen and
laminin gene expression was noted in isolated glomeruli. Two
observations of this study suggest that the accumulation of
matrix proteins reflects a true overproduction rather than a
non-specific increase of protein and gene expression due to the
transient mesangial cell hyperplasia or a decreased degradation
of the extracellular matrix; mRNA expression for collagen IV
and laminin increased nine-fold, while mesangial cell numbers
have been shown to increase no more than two- to three-fold
[25] and secondly, an apparent de novo mesangial staining and
de novo glomerular gene expression for type I collagen was
noted in diseased animals. The increase in extracellular matrix
components following a single episode of mesangial immune
injury did not persist or lead to sclerosis in the majority of
glomeruli, an observation consistent with earlier reports of only
mild focal [13] or no [27, 28] glomerular sclerotic changes one or
three months after disease induction. However, others have
shown that repeated injection of anti-thymocyte serum over
several weeks, a situation perhaps more analogous to human
diseases associated with mesangial matrix expansion, does lead
to histologic evidence of sclerosis [29 and H. lida, unpublished
observation].
The composition and distribution of pathological glomerular
matrix accumulations in various disease entities has been
shown to vary [3]. In some sclerosis models and human
diseases only glomerular type IV collagen, which can be
produced by all intrinsic glomerular cells [30, 31], increased
with time [2]. In contrast, in other experimental or human
conditions interstitial collagens (that is, types I and III) were
also detected within sclerotic glomeruli [3, 5, 6, 32]. This
appearance of interstitial collagens in the sclerotic lesions has
been attributed to a disruption of Bowman's capsule and
increased numbers of periglomerular interstitial cells [3]. How-
ever, the present study as well as two other recent studies [5,
331 in different models demonstrated that an apparent de novo
expression of interstitial collagen types can also occur in
glomerular diseases which are not characterized by disruptions
of Bowman's capsule or by periglomerular fibrosis. We cannot
exclude the possibility that hybridization conditions or probe
specificity in our study prevented detection of small amounts of
Fig. 6. Northern analysis of total glomerular RNA (15 jsg/lane) ob-
tained in normal rats (ni), in rats with anti-Thy 1.1 glomerulonephritis
at days 1 (dl), 3 (d3) and 5 (d5) as well as in complement-depleted rats
with anti-Thy 1.1 glomerulonephritis at day 3 (d3 CVF)for the expres-
sion of collagen land IV mRNAs, laminin B2 chain mRNA, s-laminin
mRNA and 28S rRNA. Due to exposure and shortened gel running
conditions no resolution of the two bands is visible in the case of
collagen I and collagen IV transcripts. The bands present in the left two
lanes of the collagen I blot represent minor cross hybridization of the
collagen I probe with 28 S rRNA. One representative experiment is
shown.
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Table 3. Glomerular gene expression of laminin B2 chain, s-laminin
and type IV collagena in normal rats, rats with anti-Thy 1.1
glomerulonephritis (GN) or in complement-depleted (CVF) rats with
anti-Thy 1.1 glomerulonephntis
Group Laminin B2 s-Laminin Collagen IV
Normal controls 1 1 1
GN day I 1.3 0.6 0.4
GN day 3 9.7 2.9 7.2
GN day 5 8.2 2.7 8.9
CVF + GN day 3 1.1 2.2 2.2
Results are given as densitometry readings compared to that ob-
served with glomerular RNA from normal rats. Prior to this all readings
were normalized for equivalent 28S ribosomal RNA which was mea-
sured using a specific 28S cDNA probe (see Methods).
a The non-detectable mRNA expression for type I collagen in normal
controls prevented a normalization of the densitometry readings in this
case.
collagen I message in normal glomeruli. However, collectively
these findings suggest that mesangial cells in vivo may undergo
phenotypic change to produce interstitial collagen(s), a phe-
nomenon known to occur in cultured mesangial cells [30, 31].
Further evidence for a mesangial cell phenotype change in vivo
is derived from the recent observation of de novo expression of
a-smooth muscle actin in the anti-Thy 1.1 model [17].
The expression of interstitial collagens is also compatible
with the ultrastructural demonstration of 20 nm wide fibrils
(which do not contain type IV or V collagen [34]) in the
pathological glomerular matrix of rats with anti-Thy 1.1 glomer-
ulonephritis at two weeks [this study] and 6 to 10 weeks after
disease induction [27]. Our observation of missing periodicity
[34] of the fibrils suggests than instead of the typical [al (I)]2, a2
(I) heterotrimer an abberant form of collagen I may be ex-
pressed. This would be consistent with the finding of a [al (1)13
trimer form of collagen I in supernatants of cultured mesangial
cells [35]. In contrast to the time kinetics of fibril expression,
maximum immunohistochemical staining for interstitial colla-
gen was noted at day 5 in our study. In accordance with earlier
data [6] this discrepancy indicates that conventional matrix
stains are relatively insensitive in detecting early matrix accu-
mulation. In the case of silver methenamine staining this may be
due to the fact that this stain predominantly recognizes carbo-
hydrate components in organized matrix structures [36] rather
than freshly synthesized matrix proteins themselves.
In addition to collagen, laminin has repeatedly been shown to
increase in expanded glomerular matrices or sclerotic lesions
[3, 4, 32, 37—40]. In vitro data demonstrate the capability of
glomerular epithelial and mesangial cells to produce this protein
[41, 42]. In the anti-Thy 1.1 model the transient overproduction
of laminin may be of importance, since it has been shown that
laminin mediates cell-adhesion, migration and differentiation
[reviewed in 43, 44]. This matrix protein could thereby play a
prominent role in the restitution of the glomerular morphology
following the initial mesangiolysis. Little is known so far about
the recently described s-laminin, which is restricted to a subset
of basement membranes including glomerular and vascular
basement membranes [12] and which is of uncertain cellular
origin in the glomerulus. Like type I collagen, no staining of the
normal glomerular mesangial matrix has been observed for
s-laminin [121. However, unlike the apparent mesangial de novo
expression of type I collagen, no appearance of s-laminin in the
nI dl d3 d5 d3
CVF
ni dl d3 d5 dS
CVF
nI dl d3 d5 d3
CVF
Type I collagen
- 5.7 kb
4.7 kb
Type IV collagen
p6.8kb
6.2 kb
Laminin
- 8.0 kb
S-laminin
nI dl d3 d5 d3
CVF
28S rRNA
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mesangial matrix of diseased rats was noted in the present study
despite a minor (2.9-fold) upregulation of the gene expression.
Based on this finding, one may speculate that the increase in
s-laminin mRNA may derive primarily from glomerular epithe-
hal cells perhaps accompanied by a small increase in glomerular
basement membrane laminin content which would not be easily
detectable by the immunohistochemical techniques employed
here. Alternatively, abnormalities in s-laminin transcription or
s-laminin degradation by the mesangial cells cannot be ex-
cluded.
Unlike the collagens and laminin, the glomerular content of
heparan sulfate proteoglycans decreases in a numbet of renal
diseases [reviewed in 45, 46]. The resulting loss of negative
basement membrane charge is viewed as one of the key factors
governing the onset of massive proteinuria [45, 46]. In the
anti-Thy 1.1, model proteinuria usually is not a prominent
finding [13, 16] and the glomerular heparan sulfate proteoglycan
content was found to increase rather than to decrease. Our data
thereby extend a recent report of increased production of the
two chondroitin/dermatan sulfate proteoglycans biglycan and
decorin by glomeruli isolated from rats with anti-Thy 1.1
disease [8]. The cellular origin of the increased heparan sulfate
proteoglycan production remains speculative. While these pro-
teoglycans have been assumed to be mainly produced by
endothelial and glomerular epithelial cells in vitro [30, 47, 48],
recent reports indicate that mesangial cells in culture may not
only release chondroitin/dermatan sulfate proteoglycans [49,
501, but also a heparan sulfate proteoglycan species [50]. The
association of increased glomerular heparan sulfate proteogly-
can content with the resolution of proliferation is noteworthy in
that it might reflect the known inhibitory effect of heparin-like
molecules or heparan sulfate proteoglycans on various cell
types [51, 521.
In normal rats the scarce data available on entactin have
shown a predominant glomerular localization of this protein on
the cell membranes of the epithelial foot processes, along
endothelial cells and in the basement membrane [11, 531. Faint
mesangial staining for entactin was also described [11, 53],
which, however, was not apparent at the anti-entactin antibody
concentration used in this study. Like laminin, entactin has
been proposed to play a role in the interaction of extracellular
matrix and the cell surface [19, 54], possibly by forming a stable
complex with laminin [44] and it too could therefore be impor-
tant in the repair of the glomerular architecture following
anti-Thy 1.1 disease.
Only limited information is available on the stimuli increasing
matrix production by glomerular cells in vitro. Transforming
growth factor-/3 (TGF-f3), which can be released by mesangial
cells, macrophages and platelets [reviewed in 7], has been
shown to regulate the production of proteoglycans, collagen(s)
and fibronectin in mesangial cells [10, 49, 55] and of proteogly-
cans and fibronectin in glomerular epithelial cells [55, 56]. In
addition, interleukin-! (IL-l) has been reported to increase the
production of collagen by glomerular epithelial cells [571. Other
peptide growth factors, which are present in the normal or
diseased kidney such as platelet-derived growth factor (PDGF)
or epidermal growth factor might also modulate matrix synthe-
sis as demonstrated in non-glomerular cell types [reviewed in
7]. In our study the beneficial effect of complement depletion in
this model could result simply from prevention of the initial
complement-dependent mesangiolysis with its consequent
pathological sequelae. Alternatively, however, complement
factors and especially the membrane attack complex C5b-9
have been shown to have direct stimulatory effects on glomer-
ular cell matrix production [58]. In addition complement com-
ponents may indirectly affect glomerular matrix synthesis by
virtue of their ability to induce mesangial cell interleukin- 1
release [59]. Based on the above-mentioned findings, the ben-
eficial effect of complement depletion observed in the present
study could be a direct effect, resulting from an alleviation of
the intrinsic glomerular cell stimulation by activated comple-
ment, or an indirect one, resulting from a reduction of the early
chemotactic glomerular accumulation of macrophages and
platelets in Thy 1.1 glomerulonephritis [15, 25, 28] with their
array of mediators potentially affecting matrix production such
as TGF-/3, IL-l or PDGF. Whether the same mechanisms are
also responsible for the reduction of cell proliferation observed
after complement depletion, rendering proliferation and matrix
overproduction causally related events, will have to be clarified
in future studies. Recent studies have extended these observa-
tions to the in vivo setting by documenting an apparent effect of
TGF-13 on proteoglycan production in anti-Thy 1.1 nephritis [8,
91. However, the multiple factors likely to regulate extracellular
matrix production and degradation in disease states remain
largely to be defined.
Following the initial matrix overproduction, the mesangial
accumulation of all examined matrix proteins decreased at later
stages in our study. This cessation of extracellular matrix
accumulation could be due to a normalization of matrix produc-
tion as described in another experimental glomerulonephritis
model [6] and/or to an upregulation of glomerular matrix-
degrading activity. Most data currently available on matrix
degradation relate to collagen metabolism, which is viewed as a
multi-step process involving the action of specific extracellular
metalloproteinases (such as, collagenase), followed by less
specific neutral proteinases (such as, gelatinase) and finally
endocytosis and intralysosomal digestion by acid proteinases
(such as, cathepsins) [60—62]. The data available for the glomer-
ulus demonstrate that mesangial cells can release a latent form
of a neutral protease, which, once activated by yet unknown
stimuli, displays gelatinase activity plus additional collagenase
activity against insoluble type IV collagen from glomerular
basement membranes [60, 611. Preliminary data suggest that
expression of this enzyme is indeed upregulated in anti-Thy 1.1
glomerulonephritis [63].
In conclusion, the present study provides in vivo evidence for
a complement-mediated matrix overproduction by intrinsic
glomerular cells following a selective immunological mesangial
cell injury. It thereby adds a further important mechanism to
the growing list of stimuli which are potentially involved in the
development of glomerular sclerosis during the course of pro-
gressive renal diseases.
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